The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans

Gastroenterology

Volumn 115, Issue 1, 1998, Pages 67-74

  Gabe, S M ^a   Bjarnason, I ^a   Tolou Ghamari, Z ^a   Tredger, J M ^a   Johnson, P G ^a   Barclay, G R ^a   Williams, R ^a   Silk, D B A ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; ENDOTOXIN ANTIBODY; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CALORIMETRY; CELL ENERGY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; LIVER TRANSPLANTATION; MALE; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; RESPIRATORY QUOTIENT;

EID: 0031749892     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70366-X     Document Type: Article

References (39)

1. European FK506 Multicenter Liver Study Group Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection Lancet 344 1994 423 428
2. U.S. Multicenter FK506 Liver Study Group A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation N Engl J Med 331 1994 1110 1115
3. GB Klintmalm R Goldstein T Gonwa RH Wiesner RA Krom BW Shaw Jr R Stratta NL Ascher JW Roberts J Lake RW Busuttil S McDiarmid CO Esquivel P Nakazo JW Marsh ES Woode M Kalayoglu AM D'Alessaandro JD Pirsch C Miller M Schwartz WD Lewis AP Monaco RL Jenkins JC Edmond JR Thistlethwaite PF Whitington DR Steinmuller WE Fitzsimmons I. Laurence Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. U.S. Multicenter FK 506 Liver Study Group Transplant Proc 25 1993 679 688
4. A Fisher M Schwartz E Mor P Sheiner S Emre S Guy C. Miller Gastrointestinal toxicity associated with FK 506 in liver transplant recipients Transplant Proc 26 1994 3106 3107
5. TE Starzl JJ Fung M Jordan R Shapiro A Tzakis J McCauley J Johnston Y Iwaki A Jain M Aiessiani S. Todo Kidney transplantation under FK506 JAMA 264 1990 63 67
6. KL Madsen NL Yanchar DL Sigalet T Reigel RN Fedorak FK506 increases permeability in rat intestine by inhibiting mitochondrial function Gastroenterology 109 1995 107 114
7. I Bjarnason J Hayllar A Macpherson AS Russell Side effects of nonsteroidal anti-inflammatory drugs of the small and large intestine in humans Gastroenterology 104 1993 1832 1847
8. S Somasundaram S Rafi J Hayllar G Sigthorsson M Jacob AB Price A Macpherson T Mahmud D Scott JM Wrigglesworth I. Bjarnason Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID-induced injury to the rat intestine Gut 41 1997 344 353
9. T Mahmud SS Rafi DL Scott JM Wrigglesworth I. Bjarnason Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation Arthritis Rheum 39 1996 1998 2003
10. JL Madara C Parkos S Colgan A Nusrat K Atisook P. Kaoutzani The movement of solutes and cells across tight junctions Ann NY Acad Sci 664 1992 47 60
11. I Bjarnason A Macpherson D. Hollander Intestinal permeability: an overview Gastroenterology 108 1995 1566 1581
12. BH Lauterburg D Liang FA Schwarzenbach KJ Breen Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis Hepatology 17 1993 418 422
13. AE Harper RH Miller KP Block Branched-chain amino acid metabolism Annu Rev Nutr 4 1984 409 454
14. PA Michaletz L Cap E Alpert BH Lauterburg Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid Hepatology 10 1989 829 832
15. BH Lauterburg I Grattagliano R Gmur M Stalder P. Hildebrand Non-invasive assessment of the effect of xenobiotics on mitochondrial function in human beings: studies with acetylsalicylic acid and ethanol with the use of the carbon 13-labelled ketoisocaproate breath test J Lab Clin Med 125 1995 378 383
16. 13C]ketoisocaproate is impaired in alcoholics Alcohol Clin Exp Res 18 1994 951 955
17. IS Menzies Transmucosal passage of inert molecules in health and disease E Skadhauge K Heinze Intestinal absorption and secretion. Falk Symposium 36 1984 MTP Lancaster, England 527 543
18. K Teahon P Smethurst AJ Levi IS Menzies I. Bjarnason Intestinal permeability in patients with Crohn's disease and their first degree relatives Gut 33 1992 320 323
19. S. Iwanaga The limulus clotting reaction Curr Opin Immunol 5 1993 74 82
20. GR Barclay BB Scott Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies Infect Immun 55 1987 2706 2714
21. BB Scott GR Barclay DGE Smith F McLoughlin IR Poxton IgG antibodies to Gram-negative endotoxin in human sera. I. Lipopolysaccharide (LPS) cross-reactivity due to antibodies to LPS core Serodiagn Immunother Infect Dis 4 1990 25 38
22. W Henke K. Jung Comparison of the effects of the immunosuppressive agents FK506 and cyclosporin A on rat kidney mitochondria Biochem Pharmacol 46 1993 829 832
23. MO Jones A Pierro IA Hashim A Shenkin DA Lloyd Postoperative changes in resting energy expenditure and interleukin 6 level in infants Br J Surg 81 1994 536 538
24. RL Shanbhogue BR Bistrian RL Jenkins S Randall GL Blackburn Increased protein catabolism without hypermetabolism after human orthotopic liver transplantation Surgery 101 1987 146 149
25. EW Fredrix PB Soeters MF von Meyenfeldt WH Saris Resting energy expenditure in cancer patients before and after gastrointestinal surgery J Parenter Enteral Nutr 15 1991 604 607
26. NL Yanchar TM Riegel G Martin RN Fedorak NM Kneteman DL Sigalet Tacrolimus (FK506)—its effects on intestinal glucose transport Transplantation 61 1996 630 634
27. TM Brody Action of sodium salicylate and related compounds on tissue metabolism in vitro J Pharmacol Exp Ther 117 1956 39 51
28. MGH Smith PD Dakkins Salicylates and enzymes J Pharm Pharmacol 23 1971 729 744
29. DE Moreland Toxicology of uncouplers of oxidative phosphorylation E Hodgson PE Levi Introduction to biochemical toxicology. 1994 Appleton & Lange Norwalk, CT 345 366
30. P. Bernardi The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death Biochim Biophys Acta 1275 1996 5 9
31. A Nicolli E Basso V Petronilli RM Wenger P. Bernardi Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore and cyclosporin A-sensitive channel J Biol Chem 271 1996 2185 2192
32. 84 cells by activating potassium channels and actin disassembling (abstr) Gut 39 1996 A255
33. J Keating I Bjarnason S Somasundaram A Macpherson N Francis AB Price D Sharpstone J Smithson I Menzies BG Gazzard Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea Gut 37 1995 623 629
34. EA Deitch Multiple organ failure.Pathophysiology and potential future therapy Ann Surg 216 1992 117 134
35. RG Fiddian-Green Splanchnic ischaemia and multiple organ failure in the critically ill Ann R Coll Surg Engl 70 1988 128 134
36. JL Meakins JC Marshall The gastrointestinal tract: the “motor” of multiple organ failure Arch Surg 121 1986 197 201
37. JB Meddings I. Gibbons Discrimination of site-specific alterations in gastrointestinal permeability in the rat Gastroenterology 114 1997 83 92
38. K Teahon S Somasundaram T Smith I Menzies I. Bjarnason Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease Gut 38 1996 864 869
39. GR Barclay Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review Prog Clin Biol Res 392 1995 263 272